evaluate the pharmaceuticals company zepbound on amgen and glp-1 Drugmakers are racing to find next Wegovy. These obesity trials are ones to watch GLP-1 Pipeline Update: August 2025

For detailed information on GLP-1 see the Gut-Brain Interrelationships and Control of Feeding Behavior page

FAQ If you prefer a more visual version, check out our YouTube video here: 1

Sort of just found my passion and the answers I had been looking for with this new specialty finally after years of treating people with the Band-Aid fix it when its broken mentality instead of at the root cause. Mike has spent the last 10 years in Anti-Aging, Functional and Regenerative Medicine

I determine the ideal options after a comprehensive evaluation , including prostate volume measurement, anatomy assessment, and urinary flow testing

February 2024: Lawsuits against Saxenda manufacturer Novo Nordisk are consolidated into multidistrict litigation out of the Eastern District of Pennsylvania (MDL 3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation)

United Healthcare covers semaglutide for those with a BMI of 30 or higher, or 27 with additional conditions, often requiring prior authorization